nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinastine—ABCB1—adrenal gland cancer	0.86	1	CbGaD
Epinastine—HTR7—sympathetic nervous system—adrenal gland cancer	0.0147	0.167	CbGeAlD
Epinastine—HTR7—vein—adrenal gland cancer	0.0137	0.156	CbGeAlD
Epinastine—HTR2A—sympathetic nervous system—adrenal gland cancer	0.00916	0.104	CbGeAlD
Epinastine—HTR2A—vein—adrenal gland cancer	0.00857	0.0974	CbGeAlD
Epinastine—HTR2A—urine—adrenal gland cancer	0.00502	0.057	CbGeAlD
Epinastine—CYP3A4—urine—adrenal gland cancer	0.00465	0.0528	CbGeAlD
Epinastine—CYP2D6—urine—adrenal gland cancer	0.00457	0.0519	CbGeAlD
Epinastine—HRH2—cardiac atrium—adrenal gland cancer	0.00347	0.0394	CbGeAlD
Epinastine—HRH2—adrenal gland—adrenal gland cancer	0.00303	0.0344	CbGeAlD
Epinastine—HTR7—gonad—adrenal gland cancer	0.00177	0.0201	CbGeAlD
Epinastine—CYP2B6—adrenal cortex—adrenal gland cancer	0.00163	0.0185	CbGeAlD
Epinastine—HTR7—adrenal gland—adrenal gland cancer	0.00154	0.0175	CbGeAlD
Epinastine—ADRA1A—adrenal gland—adrenal gland cancer	0.00148	0.0169	CbGeAlD
Epinastine—CYP2B6—gonad—adrenal gland cancer	0.00135	0.0153	CbGeAlD
Epinastine—ADRA2A—gonad—adrenal gland cancer	0.0013	0.0147	CbGeAlD
Epinastine—ADRA2A—cardiac atrium—adrenal gland cancer	0.00129	0.0147	CbGeAlD
Epinastine—ADRA2A—pituitary gland—adrenal gland cancer	0.00126	0.0144	CbGeAlD
Epinastine—CYP2B6—adrenal gland—adrenal gland cancer	0.00118	0.0134	CbGeAlD
Epinastine—HRH1—adrenal gland—adrenal gland cancer	0.00115	0.0131	CbGeAlD
Epinastine—ADRA2A—adrenal gland—adrenal gland cancer	0.00113	0.0128	CbGeAlD
Epinastine—HTR2A—gonad—adrenal gland cancer	0.0011	0.0125	CbGeAlD
Epinastine—HTR2A—pituitary gland—adrenal gland cancer	0.00107	0.0122	CbGeAlD
Epinastine—HTR2A—adrenal gland—adrenal gland cancer	0.00096	0.0109	CbGeAlD
Epinastine—ABCB1—adrenal cortex—adrenal gland cancer	0.000871	0.0099	CbGeAlD
Epinastine—ABCB1—gonad—adrenal gland cancer	0.000722	0.0082	CbGeAlD
Epinastine—ABCB1—pituitary gland—adrenal gland cancer	0.000704	0.008	CbGeAlD
Epinastine—ABCB1—adrenal gland—adrenal gland cancer	0.000629	0.00714	CbGeAlD
Epinastine—Carbamazepine—ABCB1—adrenal gland cancer	0.000321	0.278	CrCbGaD
Epinastine—Trimipramine—ABCB1—adrenal gland cancer	0.000249	0.215	CrCbGaD
Epinastine—Desipramine—ABCB1—adrenal gland cancer	0.000218	0.188	CrCbGaD
Epinastine—Imipramine—ABCB1—adrenal gland cancer	0.000185	0.16	CrCbGaD
Epinastine—Amitriptyline—ABCB1—adrenal gland cancer	0.000183	0.159	CrCbGaD
Epinastine—HRH2—GPCR downstream signaling—CDC42—adrenal gland cancer	9.81e-05	0.00194	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—GNRH1—adrenal gland cancer	9.7e-05	0.00192	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—SPARC—adrenal gland cancer	9.68e-05	0.00191	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—SDHB—adrenal gland cancer	9.45e-05	0.00187	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—GNAS—adrenal gland cancer	9.37e-05	0.00185	CbGpPWpGaD
Epinastine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	8.96e-05	0.00177	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—CDC42—adrenal gland cancer	8.91e-05	0.00176	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—SPRY2—adrenal gland cancer	8.87e-05	0.00175	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	8.87e-05	0.00175	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—SDHB—adrenal gland cancer	8.86e-05	0.00175	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—GNRH1—adrenal gland cancer	8.85e-05	0.00175	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—GNRH1—adrenal gland cancer	8.68e-05	0.00172	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TSHR—adrenal gland cancer	8.65e-05	0.00171	CbGpPWpGaD
Epinastine—HTR7—GPCR ligand binding—POMC—adrenal gland cancer	8.56e-05	0.00169	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—GNAS—adrenal gland cancer	8.51e-05	0.00168	CbGpPWpGaD
Epinastine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	8.47e-05	0.00168	CbGpPWpGaD
Epinastine—ADRA2A—G alpha (i) signalling events—POMC—adrenal gland cancer	8.23e-05	0.00163	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—PRKACA—adrenal gland cancer	8.17e-05	0.00162	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—GNAS—adrenal gland cancer	8.14e-05	0.00161	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—MEN1—adrenal gland cancer	8.13e-05	0.00161	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—GNAS—adrenal gland cancer	8.12e-05	0.00161	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—GNRH1—adrenal gland cancer	8.07e-05	0.0016	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—GNRH1—adrenal gland cancer	8.05e-05	0.00159	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—PRKACA—adrenal gland cancer	8.05e-05	0.00159	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—GNRH1—adrenal gland cancer	8.04e-05	0.00159	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—GNAS—adrenal gland cancer	7.97e-05	0.00158	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—GNRHR—adrenal gland cancer	7.94e-05	0.00157	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—GNRHR—adrenal gland cancer	7.92e-05	0.00157	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—TSHR—adrenal gland cancer	7.9e-05	0.00156	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—TSHR—adrenal gland cancer	7.89e-05	0.00156	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—GNRH1—adrenal gland cancer	7.89e-05	0.00156	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—GNRHR—adrenal gland cancer	7.78e-05	0.00154	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—TSHR—adrenal gland cancer	7.74e-05	0.00153	CbGpPWpGaD
Epinastine—HTR7—Circadian rythm related genes—TP53—adrenal gland cancer	7.6e-05	0.0015	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—CDC42—adrenal gland cancer	7.52e-05	0.00149	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—GNRH1—adrenal gland cancer	7.43e-05	0.00147	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—GNAS—adrenal gland cancer	7.4e-05	0.00146	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	7.38e-05	0.00146	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SH3KBP1—adrenal gland cancer	7.37e-05	0.00146	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—GNRH1—adrenal gland cancer	7.33e-05	0.00145	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	7.29e-05	0.00144	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	7.23e-05	0.00143	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	7.22e-05	0.00143	CbGpPWpGaD
Epinastine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	7.19e-05	0.00142	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	7.19e-05	0.00142	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—GNAS—adrenal gland cancer	7.18e-05	0.00142	CbGpPWpGaD
Epinastine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	7.18e-05	0.00142	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—TSHR—adrenal gland cancer	7.18e-05	0.00142	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—TSHR—adrenal gland cancer	7.16e-05	0.00142	CbGpPWpGaD
Epinastine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	7.04e-05	0.00139	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	7.03e-05	0.00139	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—ZNRF3—adrenal gland cancer	6.94e-05	0.00137	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	6.93e-05	0.00137	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—ZNRF3—adrenal gland cancer	6.93e-05	0.00137	CbGpPWpGaD
Epinastine—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	6.88e-05	0.00136	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—CDC42—adrenal gland cancer	6.83e-05	0.00135	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	6.8e-05	0.00134	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—SPRY2—adrenal gland cancer	6.8e-05	0.00134	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	6.72e-05	0.00133	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	6.68e-05	0.00132	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TSHR—adrenal gland cancer	6.62e-05	0.00131	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	6.62e-05	0.00131	CbGpPWpGaD
Epinastine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	6.54e-05	0.00129	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—SDHB—adrenal gland cancer	6.53e-05	0.00129	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	6.53e-05	0.00129	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—GNAS—adrenal gland cancer	6.52e-05	0.00129	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	6.31e-05	0.00125	CbGpPWpGaD
Epinastine—HRH2—GPCR downstream signaling—POMC—adrenal gland cancer	6.31e-05	0.00125	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—MEN1—adrenal gland cancer	6.23e-05	0.00123	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—PRKACA—adrenal gland cancer	6.2e-05	0.00123	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—SDHB—adrenal gland cancer	6.16e-05	0.00122	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—RRM1—adrenal gland cancer	6.09e-05	0.0012	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—SDHD—adrenal gland cancer	6.09e-05	0.0012	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—POMC—adrenal gland cancer	5.73e-05	0.00113	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—RRM1—adrenal gland cancer	5.71e-05	0.00113	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—SDHD—adrenal gland cancer	5.71e-05	0.00113	CbGpPWpGaD
Epinastine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	5.49e-05	0.00109	CbGpPWpGaD
Epinastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	5.48e-05	0.00108	CbGpPWpGaD
Epinastine—HTR2A—GPCR ligand binding—POMC—adrenal gland cancer	5.48e-05	0.00108	CbGpPWpGaD
Epinastine—HRH1—GPCR ligand binding—POMC—adrenal gland cancer	5.47e-05	0.00108	CbGpPWpGaD
Epinastine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	5.38e-05	0.00106	CbGpPWpGaD
Epinastine—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	5.36e-05	0.00106	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	5.36e-05	0.00106	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CDC42—adrenal gland cancer	5.26e-05	0.00104	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—PRKACA—adrenal gland cancer	5.15e-05	0.00102	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—PRKACA—adrenal gland cancer	5.14e-05	0.00102	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IGF2—adrenal gland cancer	5.07e-05	0.001	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	5.04e-05	0.000998	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—GNAS—adrenal gland cancer	5.03e-05	0.000995	CbGpPWpGaD
Epinastine—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	4.98e-05	0.000986	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—IGF1R—adrenal gland cancer	4.9e-05	0.00097	CbGpPWpGaD
Epinastine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	4.89e-05	0.000967	CbGpPWpGaD
Epinastine—HTR7—GPCR downstream signaling—POMC—adrenal gland cancer	4.84e-05	0.000957	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—CDC42—adrenal gland cancer	4.81e-05	0.000952	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—CDC42—adrenal gland cancer	4.8e-05	0.00095	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.79e-05	0.000948	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—GNRH1—adrenal gland cancer	4.76e-05	0.000941	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—PRKACA—adrenal gland cancer	4.75e-05	0.00094	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—GNRH1—adrenal gland cancer	4.75e-05	0.000939	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	4.71e-05	0.000932	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	4.69e-05	0.000927	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	4.66e-05	0.000921	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—GNAS—adrenal gland cancer	4.6e-05	0.000909	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—GNAS—adrenal gland cancer	4.59e-05	0.000908	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—MED12—adrenal gland cancer	4.54e-05	0.000898	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	4.5e-05	0.000891	CbGpPWpGaD
Epinastine—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	4.5e-05	0.00089	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—POMC—adrenal gland cancer	4.39e-05	0.000869	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	4.38e-05	0.000866	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—CDC42—adrenal gland cancer	4.37e-05	0.000864	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—CDC42—adrenal gland cancer	4.36e-05	0.000862	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—SPRY2—adrenal gland cancer	4.35e-05	0.000861	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—SPRY2—adrenal gland cancer	4.34e-05	0.000859	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	4.33e-05	0.000856	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	4.28e-05	0.000846	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	4.26e-05	0.000843	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—MED12—adrenal gland cancer	4.26e-05	0.000842	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TSHR—adrenal gland cancer	4.24e-05	0.000839	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TSHR—adrenal gland cancer	4.23e-05	0.000837	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TERT—adrenal gland cancer	4.22e-05	0.000835	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—RRM1—adrenal gland cancer	4.21e-05	0.000833	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—SDHD—adrenal gland cancer	4.21e-05	0.000833	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	4.18e-05	0.000827	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—GNAS—adrenal gland cancer	4.18e-05	0.000826	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—GNAS—adrenal gland cancer	4.17e-05	0.000824	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	4.15e-05	0.000821	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	4.09e-05	0.000809	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CDC42—adrenal gland cancer	4.03e-05	0.000798	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SDHB—adrenal gland cancer	4.02e-05	0.000796	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—MEN1—adrenal gland cancer	3.99e-05	0.000789	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—MEN1—adrenal gland cancer	3.98e-05	0.000787	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	3.98e-05	0.000786	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—RRM1—adrenal gland cancer	3.97e-05	0.000785	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—SDHD—adrenal gland cancer	3.97e-05	0.000785	CbGpPWpGaD
Epinastine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	3.96e-05	0.000784	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	3.96e-05	0.000783	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	3.9e-05	0.000772	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IGF2—adrenal gland cancer	3.89e-05	0.000769	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	3.86e-05	0.000763	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—GNAS—adrenal gland cancer	3.85e-05	0.000762	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.8e-05	0.000751	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	3.8e-05	0.000751	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—IGF1R—adrenal gland cancer	3.76e-05	0.000743	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—BAD—adrenal gland cancer	3.67e-05	0.000727	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	3.63e-05	0.000717	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—POMC—adrenal gland cancer	3.39e-05	0.00067	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—BRAF—adrenal gland cancer	3.34e-05	0.000661	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	3.31e-05	0.000655	CbGpPWpGaD
Epinastine—HRH2—Signaling by GPCR—EGFR—adrenal gland cancer	3.24e-05	0.000641	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TERT—adrenal gland cancer	3.23e-05	0.00064	CbGpPWpGaD
Epinastine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.19e-05	0.000631	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—MED12—adrenal gland cancer	3.14e-05	0.000621	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PRKACA—adrenal gland cancer	3.1e-05	0.000614	CbGpPWpGaD
Epinastine—HTR2A—GPCR downstream signaling—POMC—adrenal gland cancer	3.1e-05	0.000612	CbGpPWpGaD
Epinastine—HRH1—GPCR downstream signaling—POMC—adrenal gland cancer	3.09e-05	0.000611	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—PRKACA—adrenal gland cancer	3.04e-05	0.000602	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—PRKACA—adrenal gland cancer	3.04e-05	0.000601	CbGpPWpGaD
Epinastine—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	3.03e-05	0.0006	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	2.98e-05	0.000589	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—MED12—adrenal gland cancer	2.96e-05	0.000585	CbGpPWpGaD
Epinastine—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	2.82e-05	0.000557	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—BAD—adrenal gland cancer	2.81e-05	0.000557	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—POMC—adrenal gland cancer	2.81e-05	0.000556	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—POMC—adrenal gland cancer	2.81e-05	0.000555	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	2.77e-05	0.000548	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	2.75e-05	0.000544	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—GNAS—adrenal gland cancer	2.68e-05	0.000531	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	2.63e-05	0.000521	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—POMC—adrenal gland cancer	2.59e-05	0.000513	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—SDHD—adrenal gland cancer	2.59e-05	0.000513	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—RRM1—adrenal gland cancer	2.59e-05	0.000513	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CDC42—adrenal gland cancer	2.58e-05	0.000511	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CDC42—adrenal gland cancer	2.58e-05	0.000509	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—BRAF—adrenal gland cancer	2.56e-05	0.000507	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	2.56e-05	0.000506	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	2.53e-05	0.0005	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—GNAS—adrenal gland cancer	2.52e-05	0.000498	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IGF2—adrenal gland cancer	2.49e-05	0.000492	CbGpPWpGaD
Epinastine—HTR7—Signaling by GPCR—EGFR—adrenal gland cancer	2.48e-05	0.000491	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IGF2—adrenal gland cancer	2.48e-05	0.000491	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—ABCB1—adrenal gland cancer	2.47e-05	0.000488	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—GNAS—adrenal gland cancer	2.47e-05	0.000488	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—GNAS—adrenal gland cancer	2.46e-05	0.000487	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	2.44e-05	0.000482	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—CTNNB1—adrenal gland cancer	2.42e-05	0.000478	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	2.42e-05	0.000478	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—IGF1R—adrenal gland cancer	2.41e-05	0.000476	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—IGF1R—adrenal gland cancer	2.4e-05	0.000475	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	2.36e-05	0.000466	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	2.35e-05	0.000465	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	2.29e-05	0.000453	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	2.26e-05	0.000448	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	2.24e-05	0.000444	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	2.19e-05	0.000433	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	2.16e-05	0.000427	CbGpPWpGaD
Epinastine—ADRA2A—Hemostasis—TP53—adrenal gland cancer	2.12e-05	0.000418	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TERT—adrenal gland cancer	2.07e-05	0.00041	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TERT—adrenal gland cancer	2.07e-05	0.000409	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	2.03e-05	0.000401	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.93e-05	0.000382	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—EGFR—adrenal gland cancer	1.91e-05	0.000379	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	1.88e-05	0.000373	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—GNAS—adrenal gland cancer	1.86e-05	0.000367	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—CTNNB1—adrenal gland cancer	1.85e-05	0.000366	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—POMC—adrenal gland cancer	1.81e-05	0.000357	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—BAD—adrenal gland cancer	1.8e-05	0.000356	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—BAD—adrenal gland cancer	1.8e-05	0.000356	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	1.76e-05	0.000349	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—GNAS—adrenal gland cancer	1.75e-05	0.000346	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	1.72e-05	0.000339	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—POMC—adrenal gland cancer	1.69e-05	0.000335	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—POMC—adrenal gland cancer	1.66e-05	0.000328	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—POMC—adrenal gland cancer	1.66e-05	0.000328	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—BRAF—adrenal gland cancer	1.64e-05	0.000324	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	1.64e-05	0.000324	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—BRAF—adrenal gland cancer	1.64e-05	0.000324	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	1.63e-05	0.000322	CbGpPWpGaD
Epinastine—HRH2—Signaling Pathways—TP53—adrenal gland cancer	1.61e-05	0.000318	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	1.61e-05	0.000318	CbGpPWpGaD
Epinastine—HTR2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.59e-05	0.000314	CbGpPWpGaD
Epinastine—HRH1—Signaling by GPCR—EGFR—adrenal gland cancer	1.59e-05	0.000314	CbGpPWpGaD
Epinastine—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	1.56e-05	0.000308	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	1.51e-05	0.000299	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	1.49e-05	0.000295	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—EGFR—adrenal gland cancer	1.47e-05	0.00029	CbGpPWpGaD
Epinastine—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	1.45e-05	0.000286	CbGpPWpGaD
Epinastine—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	1.44e-05	0.000285	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	1.41e-05	0.000279	CbGpPWpGaD
Epinastine—CYP2B6—Metabolism—PTGS2—adrenal gland cancer	1.35e-05	0.000267	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—POMC—adrenal gland cancer	1.25e-05	0.000247	CbGpPWpGaD
Epinastine—HTR7—Signaling Pathways—TP53—adrenal gland cancer	1.23e-05	0.000244	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.19e-05	0.000234	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—CTNNB1—adrenal gland cancer	1.18e-05	0.000234	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—POMC—adrenal gland cancer	1.18e-05	0.000233	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.16e-05	0.00023	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—GNAS—adrenal gland cancer	1.14e-05	0.000226	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	1.12e-05	0.000222	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.08e-05	0.000213	CbGpPWpGaD
Epinastine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	9.97e-06	0.000197	CbGpPWpGaD
Epinastine—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	9.39e-06	0.000186	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—EGFR—adrenal gland cancer	9.39e-06	0.000186	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—EGFR—adrenal gland cancer	9.37e-06	0.000185	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	9.19e-06	0.000182	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	8.54e-06	0.000169	CbGpPWpGaD
Epinastine—HTR2A—Signaling Pathways—TP53—adrenal gland cancer	7.88e-06	0.000156	CbGpPWpGaD
Epinastine—HRH1—Signaling Pathways—TP53—adrenal gland cancer	7.87e-06	0.000156	CbGpPWpGaD
Epinastine—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	7.72e-06	0.000153	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—POMC—adrenal gland cancer	7.7e-06	0.000152	CbGpPWpGaD
Epinastine—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	7.17e-06	0.000142	CbGpPWpGaD
Epinastine—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	6.14e-06	0.000121	CbGpPWpGaD
